Host: Charles Turck, PharmD, BCPS, BCCCP 

 Guest: Stephen Hanauer, MD 


 
 Dr. Turck joins Dr. Stephen Hanauer of Northwestern University to discuss some of the highlights from his upcoming presentation at the 2021 Crohn’s & Colitis Congress, a Partnership of the Crohn’s and Colitis Foundation and the American Gastroenterological Association.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stephen Hanauer, MD Dr. Turck joins Dr. Stephen Hanauer of Northwestern University to discuss some of the highlights from his upcoming presentation at the 2021 Crohn’s & Colitis Congress, a Partnership of the Crohn’s and Colitis Foundation and the American Gastroenterological Association.

Host: Charles Turck, PharmD, BCPS, BCCCP 

 Guest: Stephen Hanauer, MD 


 
 Dr. Turck joins Dr. Stephen Hanauer of Northwestern University to discuss some of the highlights from his upcoming presentation at the 2021 Crohn’s &amp; Colitis Congress, a Partnership of the Crohn’s and Colitis Foundation and the American Gastroenterological Association.

Crohn’s  Colitis Congress 2021: Incorporating IBD Therapies

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s  Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s  Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s  Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals.  The Crohn’s  Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.  
In Collaboration with

Medicine

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs. In Collaboration with

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s  Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s  Colitis Foundation&nbsp;is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s  Colitis Foundation&nbsp;is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. &nbsp;The Crohn’s  Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs. &nbsp;
In Collaboration with

Share Crohn’s Colitis Congress 2021: Incorporating IBD Therapies

Sign up to save your podcasts

Crohn’s Colitis Congress 2021: Incorporating IBD Therapies

Crohn’s Colitis Congress 2021: Incorporating IBD Therapies